European Pharmaceutical Review
DECEMBER 20, 2023
1 The changes form part of the 2020 Pharmaceutical Strategy for Europe will impact pharma and biopharma companies operating in Europe. However, it is clear that changes are likely to have meaningful impacts for biopharma players if adopted. analysis (Source: L.E.K) About the authors Sean Dyson is a Partner in L.E.K.’s
European Pharmaceutical Review
JULY 17, 2023
Automation to accelerate biopharma in next decade “Continuous manufacturing of mRNA therapeutics has vast potential; the value of being able to quickly and safely create targeted mRNA treatments for known and not-yet-known threats is immeasurable,” shared Paula T Hammond, MIT Institute Professor and head of the Department of Chemical Engineering.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
DECEMBER 12, 2023
As a biotech, what work does Innate Pharma do in the biopharma industry? In 2007, he became in charge for business development and in 2017, also became responsible of the portfolio strategy. Innate Pharma is an international clinical-stage biotechnology oncology company based in France.
Medico Reach
AUGUST 1, 2022
Whether you are a start-up looking for investment or are interested in working in venture capital (VC), the worldwide biopharma and MedTech industries are growing. In 2022, over $14 billion was funded in biopharma setup globally, and 37 major IPOs of VC-backed biotech company businesses raised a combined $4.2 CEO : Samuel Isaly.
Clarivate
OCTOBER 31, 2023
What do the years 2001, 2007, 2014, and 2022 have in common? Investment strategy Industry commentators in the biopharma industry believe the upcoming years are expected to be a period of increased dealmaking activity. In short, the biotech bubble had burst.
Clarivate
MAY 8, 2023
That was the overarching sentiment from the experienced group of biopharma leaders that formed the panel discussion chaired by Mike Ward, Clarivate Global Head of Life Sciences and Healthcare Thought Leadership, at this year’s AngloNordic Life Science conference. Timing is everything. You have to be patiently impatient,” he said.
European Pharmaceutical Review
JULY 20, 2023
Clinical Trials Information System mandatory in EU “[In] the European regulatory framework for advanced therapies, we are guided overall by REGULATION (EC) No 1394/2007,” Warner noted. Although that provides the overall framework for advanced therapies, “this is in the context of marketed advanced therapies”.
Expert insights. Personalized for you.
98 
Let's personalize your content